Literature DB >> 27494

1-N HAPA gentamicin B, a new aminoglycoside active against gentamicin resistant isolates--activity compared to other aminoglycosides.

H C Neu, K P Fu.   

Abstract

1-N HAPA gentamicin B is a new aminoglycoside active against most Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus. Among 504 clinical isolates at a concentration of 12.5 microgram/ml all Staph. aureus, Escherichia coli, Klebsiella, Enterobacter, Proteus rettgeri, Providencia and 78% of Pseudomonas, 86% of Proteus morganii were inhibited. Like other aminoglycosides, the activity was greatest at an alkaline ph and reduced by high cations concentrations. 1-N HAPA gentamicin B was equal in activity to amikacin against both gentamicin-sensitive and resistant isolates. It inhibited bacteria containing many of the aminoglycoside inactivating enzymes. When combined with carbenicillin it inhibited in a synergistic manner many Gram-negative bacteria, particularly Pseudomonas and Serratia.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 27494     DOI: 10.7164/antibiotics.31.385

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  6 in total

1.  Pharmacokinetics of isepamicin following a single administration by intravenous infusion or intramuscular injections.

Authors:  E Radwanski; V Batra; M Cayen; C Korduba; D Cutler; M Affrime; A Nomeir; C C Lin
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

Review 2.  Aminoglycoside research 1975-1985: prospects for development of improved agents.

Authors:  K E Price
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

3.  Pharmacokinetics and metabolism of 14C-isepamicin in humans following intravenous administration.

Authors:  C Lin; C Korduba; M Affrime; E Radwanski; A Nomeir; V Batra; D Cutler; M N Cayen
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

4.  Interpretive standards for disk susceptibility tests with Sch 21420 and amikacin.

Authors:  A L Barry; C Thornsberry; R N Jones; E H Gerlach
Journal:  Antimicrob Agents Chemother       Date:  1980-10       Impact factor: 5.191

5.  Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycin.

Authors:  C Thornsberry; A L Barry; R N Jones; C N Baker; R E Badal; R R Packer
Journal:  Antimicrob Agents Chemother       Date:  1980-08       Impact factor: 5.191

6.  Pharmacokinetics of intravenously administered isepamicin in men.

Authors:  C C Lin; E Radwanski; C Korduba; M Cayen; M Affrime
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.